Acute heart failure following platinum and taxane-based chemotherapy for high grade ovarian cancer

Acute heart failure following platinum and taxane-based chemotherapy for high grade ovarian cancer

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Danielle S. Lewis, Jerry John, Shannon D. Armbruster
التنسيق:	مقال
اللغة:	English
منشور في:	Elsevier 2025-02-01
سلاسل:	Gynecologic Oncology Reports
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2352578925000141

مواد مشابهة

A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
حسب: Yixin Liu, وآخرون
منشور في: (2019-10-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
حسب: Alex Molassiotis, وآخرون
منشور في: (2019-06-01)

Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy
حسب: Hiroaki Nagano, وآخرون
منشور في: (2016-03-01)

Palliative chemotherapy in carcinoma penis: Does platinum and taxane combination holds a promise?
حسب: Vijay M Patil, وآخرون
منشور في: (2014-01-01)

Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers
حسب: Tibor A. Zwimpfer, وآخرون
منشور في: (2024-01-01)

Platinum drugs and taxanes: can we overcome resistance?
حسب: Elena V. Sazonova, وآخرون
منشور في: (2021-06-01)

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
حسب: Markowska Janina, وآخرون
منشور في: (2008-01-01)

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
حسب: Felisiak-Golabek Anna, وآخرون
منشور في: (2011-11-01)

Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC.
حسب: Seth A Brodie, وآخرون
منشور في: (2014-01-01)

Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer
حسب: Eun Kyo Joung, وآخرون
منشور في: (2021-01-01)

The effects and mechanism of taxanes on chemotherapy-associated ovarian damage: A review of current evidence
حسب: Chuqing Wu, وآخرون
منشور في: (2022-11-01)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
حسب: Shirin Kianersi, وآخرون
منشور في: (2023-01-01)

Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms
حسب: Satoshi Imai, وآخرون
منشور في: (2017-07-01)

Sequential Treatment of Advanced Squamous Lung Cancer:  First-line Gemcitabine +/- platinum Followed by Second-line Taxanes +/- platinum Versus Reverse Sequence
حسب: Jing XU, وآخرون
منشور في: (2015-05-01)

Cell death in cancer chemotherapy using taxanes
حسب: Ana P. Xu, وآخرون
منشور في: (2024-01-01)

Beau’s Lines Resulting from Taxane Chemotherapy
حسب: Kumpol Aiempanakit
منشور في: (2018-10-01)

Genome-wide study of response to platinum, taxane, and combination therapy in ovarian cancer: in vitro phenotypes, inherited variation, and disease recurrence
حسب: Brooke L Fridley, وآخرون
منشور في: (2016-03-01)

Circulating serum miRNAs predict response to platinum chemotherapy in high‐grade serous ovarian cancer
حسب: Kazuhiro Suzuki, وآخرون
منشور في: (2024-11-01)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
حسب: Kaname Uno, وآخرون
منشور في: (2022-03-01)

Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin
حسب: Ryutaro Onaga, وآخرون
منشور في: (2023-06-01)

Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
حسب: Irina Larionova, وآخرون
منشور في: (2024-09-01)

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
حسب: Lan G. Coffman, وآخرون
منشور في: (2022-09-01)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
حسب: T M Anoop, وآخرون
منشور في: (2022-01-01)

RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer
حسب: Sarah J. Taylor, وآخرون
منشور في: (2024-04-01)

3468 Predictive biomarkers of platinum-based chemotherapy response in Puerto Rican Hispanics with high-grade serous ovarian cancer.
حسب: Jeyshka M. Reyes-Gonzalez, وآخرون
منشور في: (2019-03-01)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
حسب: Amelia M. Jernigan, وآخرون
منشور في: (2013-01-01)

Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
حسب: Zheng Feng, وآخرون
منشور في: (2023-03-01)

Development and Validation of an Immune-Related Gene-Pair Model of High-Grade Serous Ovarian Cancer After Platinum-Based Chemotherapy
حسب: Jiaxing Lin, وآخرون
منشور في: (2021-02-01)

Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy studyResearch in context
حسب: Indra A. Van Assche, وآخرون
منشور في: (2024-12-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
حسب: Sumedha Shastry, وآخرون
منشور في: (2023-11-01)

Chemotherapy Associated Ovarian Failure
حسب: Davide Mauri, وآخرون
منشور في: (2020-12-01)

Establishment and Genetic Profiling of Platinum/Taxane Doublet-Resistant Cells Generated by Hybridizing Single Resistant Cells
حسب: Seiji Isonishi, وآخرون
منشور في: (2022-09-01)

Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors
حسب: Robert Knoerl, وآخرون
منشور في: (2021-09-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
حسب: İlker Selçuk, وآخرون
منشور في: (2015-04-01)

Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer
حسب: Jiao Liu, وآخرون
منشور في: (2023-11-01)

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
حسب: Carlos J Diaz Osterman, وآخرون
منشور في: (2019-09-01)

Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy
حسب: Chuan-Jen Hung, وآخرون
منشور في: (2022-10-01)

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
حسب: Du Y, وآخرون
منشور في: (2018-11-01)

Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis
حسب: Yue Zhao, وآخرون
منشور في: (2022-09-01)

Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape.
حسب: Ramya Ganesan, وآخرون
منشور في: (2023-09-01)